AMPHOTERICIN-B THERAPY OF HISTOPLASMOSIS

被引：0

|

作者：

SUTLIFF, WD

机构：

来源：

AMERICAN REVIEW OF RESPIRATORY DISEASE | 1960年 / 81卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

收藏

页码：950 / 950

页数：1

相关论文

共 50 条

[41] AMPHOTERICIN-B THERAPY - PAST, PRESENT, AND FUTURE
PEACOCK, JE
HERRINGTON, DA
CRUZ, JM
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1993, 2 (02) : 81 - 93
[42] ENHANCED EFFICACY OF AMPHOTERICIN-B AND RIFAMPICIN COMBINED IN TREATMENT OF MURINE HISTOPLASMOSIS AND BLASTOMYCOSIS
KITAHARA, M
KOBAYASHI, GS
MEDOFF, G
JOURNAL OF INFECTIOUS DISEASES, 1976, 133 (06): : 663 - 668
[43] FACTORS RELATING TO RECURRENCE OF CHRONIC PULMONARY HISTOPLASMOSIS FOLLOWING TREATMENT WITH AMPHOTERICIN-B
LOWELL, JR
MCLARTY, JW
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1983, 285 (01): : 13 - 23
[44] Amphotericin-B/infliximabHaemophagocytic lymphohistiocytosis, disseminated histoplasmosis and lack of efficacy: case report
Reactions Weekly, 2020, 1829 (1) : 49 - 49
[45] SUCCESSFUL TREATMENT OF PROGRESSIVE DISSEMINATED HISTOPLASMOSIS WITH AMPHOTERICIN-B METHYL-ESTER
NEIHART, RE
HINTHORN, DR
HOEPRICH, PD
LIU, C
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (01) : 17 - 19
[46] AMPHOTERICIN-B LIPID COMPLEX [ABLC] IN THE MANAGEMENT OF SERIOUS SYSTEMIC MYCOSES IN PATIENTS INTOLERANT TO AMPHOTERICIN-B THERAPY
LISTER, J
BLOOD, 1994, 84 (10) : A306 - A306
[47] PHARMACOLOGIC RATIONALE FOR PULSE THERAPY OF HISTOPLASMOSIS WITH AMPHOTERICIN B
FIELDS, BT
BATES, JH
ARDOIN, R
ABERNATH.RS
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1971, 103 (06): : 877 - &
[48] Amphotericin-B/amphotericin-B liposomal/voriconazoleVarious toxicities: case report
Reactions Weekly, 2016, 1583 (1) : 85 - 85
[49] Amphotericin-B/amphotericin-B liposomal/immunosuppressantsVarious toxicities: case report
Reactions Weekly, 2019, 1749 (1) : 42 - 42
[50] STABILITY STUDIES WITH AMPHOTERICIN-B AND AMPHOTERICIN-B METHYL-ESTER
BONNER, DP
MECHLINSKI, W
SCHAFFNER, CP
JOURNAL OF ANTIBIOTICS, 1975, 28 (02): : 132 - 135

← 1 2 3 4 5 →